Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Evans

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Plos One|October 21, 2024
Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysisDenise Evans, Kamban Hirasen, Clive Ramushu, et al.
BMJ Open|June 12, 2017
Cohort profile: the Right to Care Clinical HIV Cohort, South AfricaMatthew P Fox, Mhairi Maskew, Alana T Brennan, et al.
Bulletin of the World Health Organization|June 10, 2020
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trialJason J Madan, Laura Rosu, Mamo Girma Tefera, et al.
PLOS Global Public Health|March 24, 2023
Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districtsJoshua P Murphy, Sharon Kgowedi, Lezanie Coetzee, et al.
Brain Sciences|June 27, 2024
Neonatal Physical Growth Predicts Electroencephalography Power in Rural South African ChildrenAmanda R Tarullo, Denise Evans, Lezanie Coetzee, et al.
Global Health Action|January 25, 2021
Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in AfricaDenise Evans, Craig van Rensburg, Caroline Govathson, et al.
Journal of Clinical Microbiology|February 12, 2025
Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and ZambiaTiana C Schwab, Lavania Joseph, Andrew Moono, et al.
BMC Pulmonary Medicine|January 9, 2019
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocolAndrea Rachow, Olena Ivanova, Robert Wallis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Evaluating tuberculosis treatment outcomes and predictors in five Southern African countries: A multi-country cohort analysisMirriam Ndhlovu, Leticia Wuethrich, Jacqueline Huwa, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Plos One|October 21, 2024
Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysisDenise Evans, Kamban Hirasen, Clive Ramushu, et al.
BMJ Open|June 12, 2017
Cohort profile: the Right to Care Clinical HIV Cohort, South AfricaMatthew P Fox, Mhairi Maskew, Alana T Brennan, et al.
Bulletin of the World Health Organization|June 10, 2020
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trialJason J Madan, Laura Rosu, Mamo Girma Tefera, et al.
PLOS Global Public Health|March 24, 2023
Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districtsJoshua P Murphy, Sharon Kgowedi, Lezanie Coetzee, et al.
Brain Sciences|June 27, 2024
Neonatal Physical Growth Predicts Electroencephalography Power in Rural South African ChildrenAmanda R Tarullo, Denise Evans, Lezanie Coetzee, et al.
Global Health Action|January 25, 2021
Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in AfricaDenise Evans, Craig van Rensburg, Caroline Govathson, et al.
Journal of Clinical Microbiology|February 12, 2025
Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and ZambiaTiana C Schwab, Lavania Joseph, Andrew Moono, et al.
BMC Pulmonary Medicine|January 9, 2019
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocolAndrea Rachow, Olena Ivanova, Robert Wallis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Evaluating tuberculosis treatment outcomes and predictors in five Southern African countries: A multi-country cohort analysisMirriam Ndhlovu, Leticia Wuethrich, Jacqueline Huwa, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
Pageof 10